Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Edwin McElroy"'
Autor:
Satyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, Patrick C Flannery, Mohammed Majrashi, Mohammed Almaghrabi, Manoj Govindarajulu, Sindhu Ramesh, Maninder Sandey, Suneel K Onteru, Chen-Che J Huang, Yoshimi Iwaki, Kristina Gill, Natasha Narayanan, Edwin McElroy, Darshini Desai, Rishi Nadar, Timothy Moore, Muralikrishnan Dhanasekaran
Publikováno v:
Liver Research, Vol 5, Iss 4, Pp 239-242 (2021)
Background and aims: Chronic exposure to chemotherapeutics can lead to severe adverse events including hepatotoxicity. A combination chemotherapy regimen of doxorubicin (DOX) and cyclophosphamide (CPS) is employed in treatment of several cancers such
Externí odkaz:
https://doaj.org/article/b543ccd923174a20bc3ae2a759de9786
Autor:
Mohammed Majrashi, Rishi Nadar, Yoshimi Iwaki, Patrick C. Flannery, Darshini Desai, Timothy Moore, Manoj Govindarajulu, Sindhu Ramesh, Kristina Gill, Natasha Narayanan, Muralikrishnan Dhanasekaran, Suneel Kumar Onteru, Chen‐Che Huang, Maninder Sandey, Edwin McElroy, Kodye L. Abbott, Julia M. Salamat, Satyanarayana R. Pondugula, Mohammed Almaghrabi
Publikováno v:
Liver Res
Liver Research, Vol 5, Iss 4, Pp 239-242 (2021)
Liver Research, Vol 5, Iss 4, Pp 239-242 (2021)
Background and aims Chronic exposure to chemotherapeutics can lead to severe adverse events including hepatotoxicity. A combination chemotherapy regimen of doxorubicin (DOX) and cyclophosphamide (CPS) is employed in treatment of several cancers such
Autor:
Darshini Desai, Manoj Govindarajulu, Timothy Moore, Edwin McElroy, Satyanarayana R. Pondugula, Eddie Fahoury, Mohammed Almaghrabi, Rishi Nadar, Kristina Gill, Kodye L. Abbott, Muralikrishnan Dhanasekaran, Sindhu Ramesh, Mohammed Majrashi, Natasha Narayanan
Publikováno v:
Toxicology Mechanisms and Methods. 30:454-461
Endogenous (hyperglycemia) and exogenous (therapeutic, prophylactic, street drugs) factors can considerably contribute to cognitive impairment (CI). Currently, there are few invasive and/or noninvasive markers that correlate with CI and those that do
Autor:
Natasha Narayanan, Darshini Desai, Manoj Govindarajulu, Julia M. Salamat, Mohammed Almaghrabi, Elizabeth Ledbetter, Suneel Kumar Onteru, Rishi Nadar, Sindhu Ramesh, Timothy Moore, Maninder Sandey, Chen‐Che Huang, Kaylie Ward, Patrick C. Flannery, Muralikrishnan Dhanasekaran, Mohammed Majrashi, Yoshimi Iwaki, Edwin McElroy, Kristina Gill, Kodye L. Abbott, Satyanarayana R. Pondugula
Publikováno v:
The FASEB Journal. 35
Autor:
Manoj Govindarajulu, Sindhu Ramesh, Muralikrishnan Dhanasekaran, Natasha Narayanan, Darshini Desai, Kodye L. Abbott, Edwin McElroy, Patrick C. Flannery, Timothy Moore, Suneel Kumar Onteru, Satyanarayana R. Pondugula, Mohammed Majrashi, Kalyanam Nagabhushanam, Chen‐Che Huang, Maninder Sandey, Julia M. Salamat, Rishi Nadar, Kristina Gill, Muhammed Majeed, Mohammed Almaghrabi
Publikováno v:
Nat Prod Commun
Background Botanical supplements have been proven to provide beneficial health effects. However, they can induce unintended adverse events such as hepatotoxicity. Oroxylum indicum extract (OIE, Sabroxy®) has several health benefits including anti-in
Autor:
Kodye L. Abbott, Mohammed Almaghrabi, Darshini Desai, Edwin McElroy, Muhammed Majeed, Timothy Moore, Natasha Narayanan, Kalyanam Nagabhushanam, Kristina Gill, Eddie Fahoury, Sindhu Ramesh, Manoj Govindarajulu, Muralikrishnan Dhanasekaran, Rishi Nadar, Mohammed Majrashi, Satyanarayana R. Pondugula
Publikováno v:
The FASEB Journal. 34:1-1
Autor:
Julia M. Salamat, Kodye L. Abbott, Kristina Gill, Natasha Narayanan, Muhammed Majeed, Mohammed Almaghrabi, Darshini Desai, Eddie Fahoury, Sindhu Ramesh, Kalyanam Nagabhushanam, Rishi Nadar, Mohammed Majrashi, Edwin McElroy, Manoj Govindarajulu, Satyanarayana R. Pondugula, Timothy Moore, Muralikrishnan Dhanasekaran
Publikováno v:
The FASEB Journal. 34:1-1
Autor:
Jennifer L. Beaumont, Harry D. Harper, Carrie B. Lee, Thomas E. Stinchcombe, Dominic T. Moore, Mark Taylor, Kamal Bakri, Jeffrey M. Crane, Thomas A. Hensing, Harvey B. Niell, Sridhar E. Pal, Amy H. Peterman, Mark A. Socinski, Garry Schwartz, Daniel S. Bradford, Edwin McElroy
Publikováno v:
Journal of Thoracic Oncology. (9):1569-1577
Introduction Single-agent gemcitabine is a standard of care for elderly patients with advanced non-small cell lung cancer, but novel therapies are needed for this patient population. Methods We performed a noncomparative randomized phase II trial of